The molecular pathogenesis of obesity-associated endometrial cancer involves complex dysregulation of key cellular signaling networks, with the phosphatidylinositol-3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) pathway serving as a central mediator of malignant transformation. The gene discussed is AKT1; the disease is obesity disorder.